Literature DB >> 8645748

Miliary tuberculosis in a patient with Epstein-Barr virus-associated angioimmunoblastic lymphadenopathy.

R Rho1, T Laddis, C McQuain, J Selves, B Woda, H Knecht.   

Abstract

A 74-year-old woman developed angioimmunoblastic lymphadenopathy (AILD) with involvement of intra-abdominal and retroperitoneal lymph nodes. Southern blot analysis showed germline configuration of the JH genes and an oligoclonal pattern of the TcR beta genes. The immunoblasts were of B-cell phenotype and often expressed the CD30 antigen and the latent membrane protein 1 (LMP1) oncogene. Six nonsilent point mutations were identified near the 3' end of the LMP1 gene, leading to a cluster of six amino acid changes within a protein domain needed for maximal NF-kappa B stimulation. After a clinical remission of 8 months the patient relapsed with generalized lymphadenopathy and died secondary to tuberculosis. The oligoclonal rearrangements of the TcR beta genes may reflect an unsuccessful cellular immune response to Mycobacterium tuberculosis or an HLA-restricted T-cell response to B-immunoblasts expressing mutated viral antigens. A positive percutaneous tuberculin test observed 6 months prior to the onset of AILD is in favor of the first possibility.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8645748     DOI: 10.1007/s002770050182

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  13 in total

1.  Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin's disease.

Authors:  R J Lukes; B H Tindle
Journal:  N Engl J Med       Date:  1975-01-02       Impact factor: 91.245

2.  Angioimmunoblastic lymphadenopathy: common symptoms, uncommon diagnosis.

Authors:  R Sadovsky; C Zazakos
Journal:  Postgrad Med       Date:  1977-07       Impact factor: 3.840

Review 3.  Angioimmunoblastic lymphadenopathy: ten years' experience and state of current knowledge.

Authors:  H Knecht
Journal:  Semin Hematol       Date:  1989-07       Impact factor: 3.851

4.  Angio-immunoblastic lymphadenopathy with dysproteinaemia.

Authors:  G Frizzera; E M Moran; H Rappaport
Journal:  Lancet       Date:  1974-06-01       Impact factor: 79.321

5.  Miliary tuberculosis: rapid diagnosis, hematologic abnormalities, and outcome in 109 treated adults.

Authors:  G Maartens; P A Willcox; S R Benatar
Journal:  Am J Med       Date:  1990-09       Impact factor: 4.965

6.  Miliary tuberculosis: epidemiology, clinical manifestations, diagnosis, and outcome.

Authors:  J H Kim; A A Langston; H A Gallis
Journal:  Rev Infect Dis       Date:  1990 Jul-Aug

7.  Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease.

Authors:  G Pallesen; S J Hamilton-Dutoit; M Rowe; L S Young
Journal:  Lancet       Date:  1991-02-09       Impact factor: 79.321

8.  Detection of Epstein-Barr virus DNA by polymerase chain reaction in lymph node biopsies from patients with angioimmunoblastic lymphadenopathy.

Authors:  H Knecht; R Sahli; P Shaw; C Meyer; E Bachmann; B F Odermatt; F Bachmann
Journal:  Br J Haematol       Date:  1990-08       Impact factor: 6.998

9.  Angio-immunoblastic lymphadenopathy with hypogammaglobulinaemia complicated by miliary tuberculosis.

Authors:  S Hatty; G J Mufti; T J Hamblin
Journal:  Acta Haematol       Date:  1985       Impact factor: 2.195

10.  Persistence of the same viral strain in early and late relapses of Epstein-Barr virus-associated Hodgkin's disease.

Authors:  P Brousset; D Schlaifer; F Meggetto; E Bachmann; S Rothenberger; J Pris; G Delsol; H Knecht
Journal:  Blood       Date:  1994-10-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.